Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

13,577 results
MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 3
1965 1
1973 1
1989 6
1992 2
1993 2
1994 13
1995 177
1996 510
1997 494
1998 523
1999 474
2000 584
2001 535
2002 504
2003 641
2004 653
2005 680
2006 653
2007 665
2008 731
2009 675
2010 672
2011 679
2012 726
2013 833
2014 728
2015 785
2016 627
2017 584
2018 551
2019 146
Text availability
Article attribute
Article type
Publication date

Search Results

13,577 results
Results by year
Filters applied: . Clear all
Page 1
Stopping tamoxifen peri-operatively for VTE risk reduction: a proposed management algorithm
Hussain T and Kneeshaw PJ. Int J Surg 2012 - Review. PMID 22609485 Free article.
Increased risk of venous thrombo-embolism with the use of Tamoxifen is well known from published literature. This risk further increases in patients undergoing surgical procedures of high risk involving prolonged period of immobilization, therefore withholding Tamoxifen treatment in the immediate peri-operative period should be considered as a risk reducing measure. ...
Increased risk of venous thrombo-embolism with the use of Tamoxifen is well known from published literature. This risk further increases in patients undergoing surgical procedures of high risk involving prolonged period of immobilization, therefore withholding Tamoxifen treatment in the immed …
An update on the current pharmacotherapy for endometrial cancer
de Haydu C, et al. Expert Opin Pharmacother 2016 - Review. PMID 26629895
AREAS COVERED: This article reviews the current conventional therapies and discusses novel therapeutic agents, some of which are available to clinicians while others are currently being investigated in the preclinical setting. ...
AREAS COVERED: This article reviews the current conventional therapies and discusses novel therapeutic agents, some of which are available to clinicians while others are currently being investigated in the preclinical setting. ...
Tamoxifen-induced Lung Injury
Etori S, et al. Intern Med 2017. PMID 28943550 Free PMC article.
Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women
Rossi L and Pagani O. Curr Treat Options Oncol 2017 - Review. PMID 28439796
The oncologist is therefore challenged to precisely assess the risk of recurrence according to currently available predictive and prognostic factors in order to offer the most appropriate therapeutic option to the individual patient, considering also potential side effects, quality of life, pregnancy planning and patients' preferences. ...Finally, the therapeutic choice should take into account drug availability and pharmacoeconomic issues, which unfortunately may prevent, in many low-income countries, the provision of such effective treatments....
The oncologist is therefore challenged to precisely assess the risk of recurrence according to currently available predictive and prognostic factors in order to offer the most appropriate therapeutic option to the individual patient, considering also potential side effects, quality of life, p …
13,577 results
Jump to page
Feedback